This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): TM38837
Description: TM38837 is a first in class, second generation CB1 receptor antagonist. It was designed to circumvent the risk of psychiatric side effects displayed by the first generation CB1 receptor antagonists, through its restriction to peripherally located CB1 receptors in the body.
Additional information available to subscribers only: